Making science work

Individualized Medicine is a recent trend in pharmaceutical development, medical treatment and new drug applications. New active substances, including modified autologous cells obtained by Car-T technology, have received the market authorization by EMA and FDA quite recently. Significant progress in modern drug dosage forms and medical devices, including software applications, span a broad view on various treatment options by sophisticated future medicines. This is the 5th event within APV’s Winter Conference series in a row. Innovation speed and height is still there. Where are we today? Are we really prepared for the breakthrough of individualized medicines? The seminar reflects the most recent state-of-the-art in pharmaceutical development and manufacturing, indicate bright new ideas and future concepts without neglecting the constraints such as drug regulatory issues and economics. The seminar is highly recommended for pharmacists in community pharmacies, hospital pharmacies or pharmaceutical industry, other scientists or engineers operating in pharmaceutical development, manufacturing, business development and clinics.

This hot topic seminar, organized by APV’s Task Force “Individual Medicines”, is embedded in APV’s winter conference series. It will tackle obstacles such as biopharmaceutical and regulatory evaluations of flexible dosing systems, but offer some recent ideas and products to approach the future in oral medicines.